Drugs / ROTAVAC 5C -F1
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04819412 | Mar → Oct 2015 | Rotavirus infection | Bharat Biotech International Limited | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ROTAVAC 5C -F1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04819412 ↗ |
| Known as | BBIL-R2014-1 | “ROTAVAC 5C formulation BBIL-R2014-1” NCT04819412 ↗ |
| Modality | Vaccine | “ROTAVAC 5C Vaccine” NCT04819412 ↗ |